0001104659-22-022712.txt : 20220214
0001104659-22-022712.hdr.sgml : 20220214
20220214160727
ACCESSION NUMBER: 0001104659-22-022712
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
EFFECTIVENESS DATE: 20220214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Qiming U.S. Ventures Management, LLC
CENTRAL INDEX KEY: 0001909617
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-22101
FILM NUMBER: 22631634
BUSINESS ADDRESS:
STREET 1: 11100 NE 8TH ST., SUITE 200
CITY: BELLEVUE
STATE: WA
ZIP: 98004
BUSINESS PHONE: (425) 709-0772
MAIL ADDRESS:
STREET 1: 11100 NE 8TH ST., SUITE 200
CITY: BELLEVUE
STATE: WA
ZIP: 98004
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001909617
XXXXXXXX
12-31-2021
12-31-2021
false
Qiming U.S. Ventures Management, LLC
11100 NE 8th St., Suite 200
Bellevue
WA
98004
13F HOLDINGS REPORT
028-22101
N
Ryan Baker
Chief Financial Officer
425-709-0772
/s/ Ryan Baker
Bellevue
WA
02-14-2022
0
6
217303
false
INFORMATION TABLE
2
a22-6602_2informationtable.xml
INFORMATION TABLE
ELEVATION ONCOLOGY INC
COM
28623U101
14268
2370142
SH
SOLE
2370142
0
0
ICOSAVAX INC
COM
45114M109
80314
3510228
SH
SOLE
3510228
0
0
JASPER THERAPEUTICS INC
COM
471871103
45946
5852982
SH
SOLE
5852982
0
0
KEZAR LIFE SCIENCES INC
COM
49372L100
13856
828711
SH
SOLE
828711
0
0
TALARIS THERAPEUTICS INC
COM
87410C104
44840
2932606
SH
SOLE
2932606
0
0
VENTYX BIOSCIENCES INC
COM
92332V107
18079
910306
SH
SOLE
910306
0
0